Back
Global X Adaptive US Risk Management ETF Vs. NovoCure Ltd. Industry Stock Comparison
Buy
68
ONOF
Global X Adaptive US Risk Management ETF
Last Price:
$37.53
Seasonality Move:
1.39%
Sell
34
NVCR
NovoCure Ltd.
Last Price:
$12.84
Seasonality Move:
-11.64%
Buy
68
Global X Adaptive US Risk Management ETF (ONOF)
is a Buy
Is Global X Adaptive US Risk Management ETF a Buy, Sell or Hold?
-
The current Global X Adaptive US Risk Management ETF [ONOF] share price is $37.58. The Score for ONOF is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
-
ONOF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
34
NovoCure Ltd. (NVCR)
is a Sell
Is NovoCure Ltd. a Buy, Sell or Hold?
-
The current NovoCure Ltd. [NVCR] share price is $12.56. The Score for NVCR is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
NVCR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ONOF Stock Price Chart
What is Global X Adaptive US Risk Management ETF's stock price today?
-
The Global X Adaptive US Risk Management ETF share price today is $37.58The current trend is moderately bearish and ONOF is experiencing slight selling pressure.
NVCR Stock Price Chart
What is NovoCure Ltd.'s stock price today?
-
The NovoCure Ltd. share price today is $12.56Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVCR is experiencing slight selling pressure.
ONOF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.09 | Buy |
| Relative Strength Index (14 RSI): | 49.12 | Sell |
| Chaikin Money Flow: | -3785 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (36.98 - 38.06) | Buy |
| Bollinger Bands (100): | (35.78 - 37.74) | Buy |
NVCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.15 | Buy |
| Relative Strength Index (14 RSI): | 50.99 | Buy |
| Chaikin Money Flow: | -98953 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.47 - 12.93) | Buy |
| Bollinger Bands (100): | (11.53 - 13.45) | Buy |
ONOF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 37.81 | Sell |
| 20-day SMA: | 37.66 | Sell |
| 50-day SMA: | 37.49 | Buy |
| 200-day SMA: | 34.77 | Buy |
| 8-day EMA: | 37.7 | Sell |
| 20-day EMA: | 37.68 | Sell |
| 50-day EMA: | 36.77 | Buy |
| 200-day EMA: | 23.39 | Buy |
NVCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.96 | Sell |
| 20-day SMA: | 12.41 | Buy |
| 50-day SMA: | 12.6 | Sell |
| 200-day SMA: | 15.01 | Sell |
| 8-day EMA: | 12.7 | Sell |
| 20-day EMA: | 12.5 | Buy |
| 50-day EMA: | 12.57 | Sell |
| 200-day EMA: | 14.9 | Sell |
Global X Adaptive US Risk Management ETF Earnings Growth & ONOF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
NovoCure Ltd. Earnings Growth & NVCR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.09 per share, and a decrease next year of $0.10 per share.
Global X Adaptive US Risk Management ETF Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovoCure Ltd. Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||